Search Results
Results found for "Bridge Biotherapeutics"
Posts (77)
- 📰 GPCR Weekly News, December 11 to 17, 2023
This week's highlights: Kudos to our partner, GPCR Therapeutics, for partnering with Bridge Biotherapeutics meta-dynamics/FMO3 approach Industry News GPCR Therapeutics Announces Out-Licensing Agreement with Bridge Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have
- Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID-19...
November 2021 Twist Bioscience Launches Revelar Biotherapeutics to Develop and Commercialize Novel COVID offering of high-quality synthetic DNA using its silicon platform, today announced it has launched Revelar Biotherapeutics
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare disorders, today announced that the Company entered into a royalty-based financing with an affiliate of R-Bridge Healthcare Fund (the R-Bridge Financing)."
Other Pages (49)
- "Solving financial puzzles feels just like solving scientific ones," says Joe St. Germain from Company Launch Partners. Behind every successful research organization, there is a rock-solid operations team. Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe St. Germain. ✳️ Tune in now: Ep 165 with Chuck DeWeese & Joe St. Germain #gpcr #DrGPCR #ScienceStartup | Dr. GPCR Ecosystem
Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe Don’t miss this rare conversation bridging science, structure, and strategy with Chuck DeWeese & Joe
- terrys corner no fluff pure insight | Dr. GPCR Ecosystem
Bridge theory to practical drug development decisions?
- model predict discover
With a deep focus on structure-based drug design, Jens discusses how his lab bridges simulation and experiment—and Bridging computation, chemistry, and pharmacology is key to speeding up drug discovery. With a reputation for collaborative science, Jens is a strong advocate for bringing together chemists